PARIS--(BUSINESS WIRE)--Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI - Eligible PEA - SME), the pioneer of 2D/3D imaging and data solutions for orthopedics, today announced ...

EOS imaging also announces today the signature of a binding agreement with Fosun Pharmaceutical AG, an indirect subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., related to an equity ...

EOS imaging is a leader in outcome-improving orthopedic medical imaging and software solutions, and is globally recognized for its rapid, low dose, biplanar full-body imaging and 3D modeling ...

EOS imaging announced two new installations of the EOS imaging system in AP-HP public hospitals in Paris. The Lariboisière hospital will use the system for spine and joint pathologies in adults. The ...

The FDA has granted 510(k) clearance to EOS Imaging for its updated sterEOS 3-D imaging software. The improved sterEOS provides a 3-D model of the spine and lower limbs for diagnosis and surgical ...

PARIS, May 12, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) and EOS IMAGING, S.A. are pleased to report strong progress in the tender offer filed by ATEC for the common shares and ...

Hospital for Special Surgery installed its fourth EOS imaging system for 3D anatomical modeling and surgical planning. HSS, which is the world’s largest academic medical center dedicated to ...

* FY operating loss of 4.6 million euros ($4.97 million) versus loss of 6.7 million euros year ago * FY net loss of 6.2 million euros versus loss of 7.2 million euros year ago * Net cash at Dec 31 ...